Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III …
…, RM Bremnes, S Kaasa, U Aasebø… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: To investigate whether chemotherapy with etoposide and cisplatin (EP) is superior
to cyclophosphamide, epirubicin, and vincristine (CEV) in small-cell lung cancer (SCLC). …
to cyclophosphamide, epirubicin, and vincristine (CEV) in small-cell lung cancer (SCLC). …
[PDF][PDF] Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy …
…, F Stornes, T Tollåli, F Wammer, U Aasebø… - Clin Oncol, 2009 - academia.edu
… Hjelde, Stein Kaasa, Christian von Plessen, Frøydis Stornes, Terje Tollåli, Finn Wammer,
Ulf Aasebø, and Stein Sundstrøm … Brunsvig, Christian von Plessen, Ulf Aasebø, Stein …
Ulf Aasebø, and Stein Sundstrøm … Brunsvig, Christian von Plessen, Ulf Aasebø, Stein …
The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up
RM Bremnes, S Sundstrom, U Aasebø, S Kaasa… - Lung cancer, 2003 - Elsevier
We have evaluated the prognostic value of 22 pretreatment attributes in 436 small cell lung
cancer (SCLC) patients included in a prospective multicenter study with a minimum 5-year …
cancer (SCLC) patients included in a prospective multicenter study with a minimum 5-year …
Hypofractionated palliative radiotherapy (17 gy per two fractions) in advanced non–small-cell lung carcinoma is comparable to standard fractionation for symptom …
S Sundstrøm, R Bremnes, U Aasebø… - Journal of clinical …, 2004 - ascopubs.org
Purpose To investigate whether the effect of hypofractionated thoracic radiotherapy (TRT) is
comparable to more standard fractionated radiotherapy (RT) in advanced non–small-cell …
comparable to more standard fractionated radiotherapy (RT) in advanced non–small-cell …
[PDF][PDF] Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial
…, L Thaning, J Vilsvik, U Aasebø… - Journal of Clinical …, 2008 - researchgate.net
Purpose A Japanese randomized trial showed superior survival for patients with extensive-disease
(ED) small-cell lung cancer (SCLC) receiving irinotecan plus cisplatin compared with …
(ED) small-cell lung cancer (SCLC) receiving irinotecan plus cisplatin compared with …
Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy
U Aasebø, A Gyltnes, RM Bremnes, A Aakvaag… - The Journal of steroid …, 1993 - Elsevier
Erectile impotence is commonly encountered in male patients with respiratory failure and
hypoxia. In this study, 42% of the patients experienced reversal of sexual impotence during …
hypoxia. In this study, 42% of the patients experienced reversal of sexual impotence during …
The Diagnosis of Adult Pneumonia in General Practice: The Diagnostic Value of History, Physical Examination and Some Blood Tests
H Melbye, BØR Straume, U Aasebø… - Scandinavian journal of …, 1988 - Taylor & Francis
Because of lower respiratory infection that was treated with antibiotics on the suspicion of
pneumonia, 71 patients aged 15 years or more were referred to the study by general …
pneumonia, 71 patients aged 15 years or more were referred to the study by general …
[PDF][PDF] Pulmonary function in long-term survivors of testicular cancer
…, SD Fosså, O Dahl, M Brydøy, U Aasebø… - Journal of Clinical …, 2009 - researchgate.net
Results Median observation time was 11.2 years (range, 5 to 21 years). Compared with the
surgery group, the higher-dose or cis/pulmsurg groups had considerably lower age-adjusted …
surgery group, the higher-dose or cis/pulmsurg groups had considerably lower age-adjusted …
[HTML][HTML] Low oxygen saturation and mortality in an adult cohort: the Tromsø study
ML Vold, U Aasebø, T Wilsgaard, H Melbye - BMC pulmonary medicine, 2015 - Springer
Background Oxygen saturation has been shown in risk score models to predict mortality in
emergency medicine. The aim of this study was to determine whether low oxygen saturation …
emergency medicine. The aim of this study was to determine whether low oxygen saturation …
A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non …
…, M Krzakowski, AP Smith, E Saigi, U Aasebo… - Lung cancer, 2000 - Elsevier
This was an open-label randomized Phase III study of 207 patients with either unresectable
or metastatic non-small cell lung cancer (NSCLC) who were treated with docetaxel plus best …
or metastatic non-small cell lung cancer (NSCLC) who were treated with docetaxel plus best …